Navigation Links
Centocor Ortho Biotech Receives FDA Complete Response Letter Regarding DOXIL(R) for the Treatment of Advanced Breast Cancer
Date:9/10/2009

se of doxorubicin HCl approaches 550 mg/m2
  • Prior use of other anthracyclines or anthracenediones should be included in calculations of total cumulative dose
  • Cardiac toxicity may also occur at lower cumulative doses (400 mg/m2) in patients with prior mediastinal irradiation or who are receiving concurrent cyclophosphamide therapy
  • Acute infusion-related reactions including, but not limited to, flushing, shortness of breath, facial swelling, headache, chills, back pain, tightness in the chest or throat, and/or hypotension have occurred in up to 10% of patients treated with DOXIL. In most patients, these reactions have resolved within several hours to a day once the infusion is terminated. In some patients, reactions resolved with slowing of the infusion rate
    • Serious and sometimes life-threatening or fatal allergic/anaphylactoid-like infusion reactions have occurred. Medications to treat such reactions, as well as emergency equipment, should be available for immediate use
    • The initial rate of infusion should be 1 mg/min to minimize the risk of infusion reactions
  • Severe myelosuppression may occur
  • DOXIL dosage should be reduced in patients with impaired hepatic function
  • Accidental substitution has resulted in severe side effects. Do not substitute for doxorubicin HCl on a mg per mg basis
  • Contraindications

    • Patients with a history of hypersensitivity reactions to a conventional doxorubicin formulation or the components of DOXIL
    • Nursing mothers

    Additional Safety Information

    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/21/2015)... MO (PRWEB) May 21, 2015 Seventh ... the safety and efficacy of pharmaceutical products and medical ... Maryland Heights, MO 63043, a 50,000 sq. ft. building ... location, to enable strategic growth. Facility renovations will begin ... the new space will occur in September. , ...
    (Date:5/21/2015)... uBiome, the leading startup focused ... PicnicHealth, a healthcare company that collects and consolidates ... Bowel Disease (IBD) will receive a complementary PicnicHealth ... kit. Both companies were funded by Y Combinator ... more information on this partnership and how to ...
    (Date:5/21/2015)... 21, 2015 Patent Offering, The patent’s ... diagnostic or therapeutic imaging within a body lumen (open ... endoscope having a low cost, single-use disposable illumination and ... was October 18, 2013 and the patent approval was ... the physician to customize the lighting and magnification of ...
    (Date:5/21/2015)... May 21, 2015 /PRNewswire/ - RepliCel Life Sciences ... regenerative medicine company focused on the development of ... presentation at the International Society for Cellular Therapy ... Achilles tendinosis currently in a Phase 1/2 clinical ... th from 5:30 PM to 7:00 PM ...
    Breaking Biology Technology:Seventh Wave Laboratories Purchases Building for Expansion, Upcoming Move 2Seventh Wave Laboratories Purchases Building for Expansion, Upcoming Move 3uBiome Partners with PicnicHealth 2uBiome Partners with PicnicHealth 3IpAuctions™ Presents The Worlds Smallest Disposable Illuminated Endoscope For Auction 2IpAuctions™ Presents The Worlds Smallest Disposable Illuminated Endoscope For Auction 3RepliCel to Present Unique Autologous Cell Treatment for Achilles Tendinosis at International Society for Cellular Therapy Conference 2RepliCel to Present Unique Autologous Cell Treatment for Achilles Tendinosis at International Society for Cellular Therapy Conference 3
    ... today that,it has initiated coverage on Synvista Therapeutics, Inc. ... Vista Partners stated, "Synvista is one of,the best small ... conducting four Phase 2 trials in multi-billion dollar markets.,Additionally ... could begin to,produce revenues as early as next year. ...
    ... Simcere Pharmaceutical,Group (NYSE: SCR ), a leading manufacturer ... anti-cancer biotech,product Endu in China, today announced that the Company,s ... * Brean Murray Carret & Co. All Cap China ... York on Monday, May 19, 2008 at 2:00 p.m. ET, ...
    ... Medical Systems delivers faster image-guided,intensity-modulated radiotherapy (IMRT) to target tumors ... ... healthy tissue, COPENHAGEN, Denmark and AMSTERDAM, Netherlands, May ... Europe,s first clinical treatments using advanced,RapidArc(TM) technology from Varian Medical ...
    Cached Biology Technology:Vista Partners Initiates Coverage on Synvista Therapeutics, Inc. (AMEX: SYI) 2Simcere Pharmaceutical Group to Participate in Upcoming Investor Conferences in New York 2Top Cancer Hospitals in Denmark and Netherlands First in Europe to Treat Patients With RapidArc(TM) Radiotherapy 2Top Cancer Hospitals in Denmark and Netherlands First in Europe to Treat Patients With RapidArc(TM) Radiotherapy 3
    (Date:5/14/2015)... , May 14, 2015  Verificient ... identity verification and online remote proctoring, announced ... software-as-a-service (SaaS) company and creator of the ... of the two companies will benefit from ... Canvas. As a fully integrated ...
    (Date:5/10/2015)... May 11, 2015 Fingerprint Cards (FPC) ... and FPC1155 from the distributor World Peace Industrial Group (WPI), ... in Asia . Deliveries are planned to ... used by smartphone manufacturers in China . ... communicated revenue guidance of + 1 000 MSEK for 2015.   ...
    (Date:5/5/2015)... , May 5, 2015, NXT-ID, Inc. (NASDAQ: ... company focused on the growing mobile commerce market, reminds investors ... Chief Technology Officer, is presenting  at CARTES SECURE CONNEXIONS AMERICA ... 5-7, 2015. The three-day conference is organized ... is speaking in is themed Global Fraud: Where is ...
    Breaking Biology News(10 mins):Verificient and Instructure Announce Alliance Partnership to Provide Online Proctoring for K-12 and Higher Education Institutions 2Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 235 Million 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 3
    ... Rutgers University has received a $3.2 million grant ... engineering, physical science and mathematical disciplines to stem ... program can equip experts in fields such as ... to move stem-cell breakthroughs from the biology lab ...
    ... University of Alaska Fairbanks neuroscientists studying stroke and ... at the 7th Conference of the Specialized Neuroscience Research ... scientists are part of the Alaska Basic Neuroscience Program ... a National Institutes of Health supported SNRP whose goal ...
    ... 19, 2008 -- Elsevier, a leading global healthcare ... The Elsevier Grand Challenge, a competition inviting the ... Sciences information is used in online text databases. ... panel of judges from among over 70 excellent ...
    Cached Biology News:$3.2M for Rutgers to apply biology, engineering, physical sciences toward stem cells 2$3.2M for Rutgers to apply biology, engineering, physical sciences toward stem cells 3Stroke and SIDS in Alaska topics of neuroscience conference 2Elsevier announces 10 semi-finalists for the Elsevier Grand Challenge 2Elsevier announces 10 semi-finalists for the Elsevier Grand Challenge 3
    ...
    ...
    ...
    ... Performance, 5 ml. The same high ... Streptavidin columns for fast, reliable purification ... Tricorn 5/50 GL, XK 16/20, or ... are required.Extremely useful for exploiting either ...
    Biology Products: